Zenith TX2 Pro-Form G53422Recalls & reported problems
William Cook Europe ApS · Zenith TX2, TAA Endovascular Graft with Pro-Form, Proximal Component · Class 3 · Implant
All models of Zenith TX2 Pro-Form (15)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10827002534220), received between Jun 7, 2016 and Jun 7, 2016 — classified as 1 malfunction.
The most frequently reported specific device problem is “Device Operates Differently Than Expected” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Device Operates Differently Than Expected1
- Difficult to Remove1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 7, 2016Difficult to Remove; Device Operates Differently Than Expected
DESCRIPTION OF EVENT ACCORDING TO COMPLAINANT: A (B)(6) FEMALE PATIENT UNDERWENT A THORACIC ENDOVASCULAR STENT GRAFT PLACEMENT PROCEDURE FOR A THORACIC AORTA DISSECTION FROM LEFT SUBCLAVIAN TO A FEW CM ABOVE CELIAC WITH SMALL ULCERATION. DURING THE PROCEDURE THE PHYSICIAN DEPLOYED THE GRAFT AND WENT TO PULL THE TRIGGER WIRE, THE THUMB SCREW CAME OFF FINE BUT AFTERWARDS THE GREEN TRIGGER WIRE RELEASE MECHANISM WOULD NOT PULL OFF; WE WERE ABOUT TO CUT THE WIRES AND HAVE HIM PULL THEM THAT WAY AFTER CHECKING TO SEE IF THERE WAS SOME TENSION BUILT UP IN THE DEPLOYMENT SYSTEM BUT AFTER A FEW MINUTES HE WAS ABLE TO FINALLY TUG THE TRIGGER WIRE RELEASE MECHANISM OFF WITHOUT HAVING TO CUT ANYTHING. THE STENT GRAFT REMAINED IN THE PATIENT'S BODY AS INTENDED BUT EVERYTHING ELSE WAS REMOVED. PATIENT OUTCOME: THE PATIENT DID NOT REQUIRE ANY ADDITIONAL PROCEDURES DUE TO THIS OCCURRENCE. ACCORDING TO THE INITIAL REPORTER, THE PATIENT DID NOT EXPERIENCE ANY ADVERSE EFFECTS DUE TO THIS OCCURRENCE.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5702747 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page